Skip to content

Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis

Efficacy of Er: YSGG Laser on Oral Biofilm Removal From Implant Surface and Its Biological Response to Periodontal Tissues in Treatment of Peri-implantitis (An Ex Vivo Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05137821
Enrollment
3
Registered
2021-11-30
Start date
2023-08-10
Completion date
2023-11-15
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Keywords

Er: YSGG laser therapy, Peri-Implantitis

Brief summary

This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective. To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.

Detailed description

This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective. To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives. The study was designed as an Ex Vivo study. Four periodontally and systemically healthy volunteers of both gender are included in this study for the formation of in vivo plaque biofilm. Each volunteer will wear a hard resin splint carrying six rough (machined implant; 3.3mm diameter, 8mm length) for 4 days to accumulate dental plaque naturally on the titanium surfaces of the implants. Therefore, 24 implants will be assessed for Er: YSGG laser therapy in different bone defect simulators.

Interventions

DEVICEEr: YSGG laser

Er: YSGG laser decontamination of infected implant surfaces to simulate peri-implantitis therapy

new sealed implant without any surface treatment

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

two group control and test group test group divided into four subgroups

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Sex: female or male. * Age: 25 - 55 years. * Medically controlled according to medical coding of review of systems (ROS)

Exclusion criteria

* Tobacco smoking for at least 6 months before the study enrollment * Participants with ill-fitting restorations in both upper first molars that affect the stability of the stent. * Participants not following oral hygiene instructions. * Participants on dental treatment during the study period. * Participants with a history of drug administration * Vulnerable group. * Participants with long-term mouthwash administration.

Design outcomes

Primary

MeasureTime frameDescription
visual inspection of the oral biofilm removal efficacy by image analysis software (Adobe Photoshop2 weeksevaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology

Secondary

MeasureTime frameDescription
Profilometer analysis of surface roughness changes1 monthassess the morphological changes of implant surface after Er: YSGG laser therapy through Profilometer analysis

Other

MeasureTime frameDescription
biocompatibility test of the surface2 monthsassess the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026